| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |